Postdiagnosis Changes in Cigarette Smoking and Survival Following Breast Cancer
- PMID: 29608187
- PMCID: PMC5875926
- DOI: 10.1093/jncics/pkx001
Postdiagnosis Changes in Cigarette Smoking and Survival Following Breast Cancer
Abstract
Background: The purpose of this study was to examine whether at-diagnosis smoking and postdiagnosis changes in smoking within five years after breast cancer were associated with long-term all-cause and breast cancer-specific mortality.
Methods: A population-based cohort of 1508 women diagnosed with first primary in situ or invasive breast cancer in 1996 to 1997 were interviewed shortly after diagnosis and again approximately five years later to assess smoking history. Participants were followed for vital status through December 31, 2014. After 18+ years of follow-up, 597 deaths were identified, 237 of which were breast cancer related. Multivariable Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
Results: Compared with never smokers, risk of all-cause mortality was elevated among the 19% of at-diagnosis smokers (HR=1.69, 95% CI=1.36 to 2.11), those who smoked 20 or more cigarettes per day (HR=1.85, 95% CI=1.42 to 2.40), women who had smoked for 30 or more years (HR=1.62, 95% CI=1.28 to 2.05), and women who had smoked 30 or more pack-years (HR=1.82, 95% CI=1.39 to 2.37). Risk of all-cause mortality was further increased among the 8% of women who were at-/post-diagnosis smokers (HR=2.30, 95% CI=1.56 to 3.39) but was attenuated among the 11% women who quit smoking after diagnosis (HR=1.83, 95% CI=1.32 to 2.52). Compared with never smokers, breast cancer-specific mortality risk was elevated 60% (HR=1.60, 95% CI=0.79 to 3.23) among at-/postdiagnosis current smokers, but the confidence interval included the null value and elevated 175% (HR=2.75, 95% CI=1.26 to 5.99) when we considered postdiagnosis cumulative pack-years. Conclusions: Smoking negatively impacts long-term survival after breast cancer. Postdiagnosis cessation of smoking may reduce the risk of all-cause mortality. Breast cancer survivors may benefit from aggressive smoking cessation programs starting as early as the time of diagnosis.
Conflict of interest statement
Notes: H. Parada declares that he has no conflict of interest. P. T. Bradshaw declares that he has no conflict of interest. S. E. Steck declares that she has no conflict of interest. L. S. Engel declares that he has no conflict of interest. K. Conway declares that she has no conflict of interest. S. L. Teitelbaum declares that she has no conflict of interest. A. I. Neugut declares that he has no conflict of interest. R. M. Santella declares that she has no conflict of interest. M. D. Gammon declares that she has no conflict of interest.
Comment in
-
Survival Benefits of Smoking Cessation After Breast Cancer Diagnosis.JNCI Cancer Spectr. 2017 Sep 21;1(1):pkx005. doi: 10.1093/jncics/pkx005. eCollection 2017 Sep. JNCI Cancer Spectr. 2017. PMID: 31360831 Free PMC article. No abstract available.
References
-
- Siegel RL, Miller KD, Jemal A.. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. - PubMed
-
- American Cancer Society. Cancer Treatment and Survivorship Facts and Figures 2014-2015. Atlanta, GA: ACS; 2014.
-
- McBride CM, Ostroff JS.. Teachable moments for promoting smoking cessation: The context of cancer care and survivorship. Cancer Control. 2003;10(4):325–333. - PubMed
-
- Westmaas JL, Newton CC, Stevens VL, Flanders WD, Gapstur SM, Jacobs EJ.. Does a recent cancer diagnosis predict smoking cessation? An analysis from a large prospective US cohort. J Clin Oncol. 2015;33(15):1647–1652. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources